TEVI CHIMERIC ENDONUCLEASE AND THEIR PREFERENTIAL CLEAVAGE SITES

    公开(公告)号:US20170260513A1

    公开(公告)日:2017-09-14

    申请号:US15466714

    申请日:2017-03-22

    Applicant: CELLECTIS S.A.

    Abstract: The present invention relates to a method to cleave target nucleic acid sequence by the catalytic domain of a GIY-YIG homing endonucleases I-TevI. More precisely, the invention relates to the deciphering of new preferential I-TevI cleavage sites for efficient and specific cleavage activity. The invention concerns a method for the generation of TevI specific chimeric endonucleases to target nucleic acid sequence including such cleavage sites and methods of using same for gene editing.

    TEVI CHIMERIC ENDONUCLEASE AND THEIR PREFERENTIAL CLEAVAGE SITES
    5.
    发明申请
    TEVI CHIMERIC ENDONUCLEASE AND THEIR PREFERENTIAL CLEAVAGE SITES 审中-公开
    TEVI CHIMERIC内切酶及其优选CLEAVAGE SITES

    公开(公告)号:US20150376585A1

    公开(公告)日:2015-12-31

    申请号:US14764933

    申请日:2014-01-29

    Applicant: CELLECTIS

    Abstract: The present invention relates to a method to cleave target nucleic acid sequence by the catalytic domain of a GIY-YIG homing endonucleases 1-Tevl. More precisely, the invention relates to the deciphering of new preferential 1-Tevl cleavage sites for efficient and specific cleavage activity. The invention concerns a method for the generation of TevI specific chimeric endonucleases to target nucleic acid sequence including such cleavage sites and methods of using same for gene editing.

    Abstract translation: 本发明涉及通过GIY-YIG归巢内切核酸酶1-Tev1的催化结构域切割靶核酸序列的方法。 更准确地说,本发明涉及用于有效和特异性切割活性的新的优先1-脱乙酰裂解位点的解密。 本发明涉及用于产生TevI特异性嵌合核酸内切酶以靶向包括这种切割位点的核酸序列的方法及其用于基因编辑的方法。

Patent Agency Ranking